Navigation Links
Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Date:9/24/2007

ected patients.

About Multiple Myeloma

Multiple Myeloma is a blood malignancy characterized by the accumulation of malignant cells in the bone marrow. The clinical manifestations of the disease are overproduction of immunoglobulin, bone destruction, bone pain, anemia, high calcium levels and kidney dysfunction. The incidence of Multiple Myeloma is especially high in African-Americans, in whom it is the most common blood cancer. Unlike the bone loss associated with other bone tumors, the Myeloma bone lesions are unique in that they do not heal or repair, despite the patients' having many years of complete remission. This may be related to the inhibition and/or loss of the bone-forming cells during disease progression and increased numbers/activity of cells causing bone loss. Thus Myeloma is a disorder that would benefit from therapies that both stimulate bone formation and retard its loss. To date, no such therapies exist and Velcura believes that VEL-0230 may help those suffering from Multiple Myeloma.

For more information on this disease, contact the Multiple Myeloma Research Foundation (http://www.multiplemyeloma.org)

About Velcura Therapeutics, Inc.

Velcura Therapeutics Inc. is an early stage biotechnology company headquartered in Ann Arbor, Michigan. Velcura's research focus is to better understand human bone disease and to discover novel therapeutics that restore bone health. Velcura develops highly differentiated therapies for bone disease; specifically, dual-acting therapies that demonstrate both anabolic bone-building and anti-bone-loss activities in a single molecule. Velcura uses its patented platform technologies to discover and optimize compounds that both simulate and inhibit bone growth. Velcura's lead compound, VEL-0230 was identified using these bone assays. More information is at http://www.velcura.com. Availabl
'/>"/>

SOURCE Velcura Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... IRVINE, Calif. , Dec. 19, 2014 /PRNewswire/ ... today that Siddhartha Kadia, Ph.D. has joined the ... and Chief Executive Officer and a director of ... high-precision laboratory testing, evaluation and analytical services to ... Prior to joining Evans Analytical Group, ...
(Date:12/19/2014)... FOREST, Ill. , Dec. 19, 2014   ... world,s leading provider of injectable drugs and infusion technologies, ... J.P. Morgan 33rd Annual Healthcare Conference on Wednesday, Jan. ... The presentation is scheduled to begin at 10:30 a.m. ... be available to all interested parties through a live ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 ... ;  Sorrento), an oncology company developing new treatments ... a privately-held immuno-oncology company developing proprietary Neukoplast ® ... therapy, announced today that the companies have entered ... generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the ...
Breaking Medicine Technology:Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... N.J., Nov. 7, 2011 MAQUET Cardiovascular, a ... that it has received U.S. Federal Trade Commission ... leader in medical device technologies for interventional cardiology ... vascular surgery, and general surgery, and has subsequently ...
... 7, 2011 Reportlinker.com announces that a new ... Refractive Surgery Devices Market Outlook ... to 2017 http://www.reportlinker.com/p0681737/Refractive-Surgery-Devices-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html ... in BRICS (Brazil, Russia, India, China, South Africa) ...
Cached Medicine Technology:MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 2MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 3Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17
(Date:12/21/2014)... OH (PRWEB) December 21, 2014 As ... men alleging heart attacks, stroke and blood clots from ... to increase, a new study shows that the male ... colon cancer. In a study published in the Proceedings ... researcher, James Amos-Landgraf examined a group of male rats ...
(Date:12/21/2014)... Concept Plus, LLC. a SDB and ... Fairfax, VA., today announced it has been recognized by ... which ranks the fastest growing government contracting small businesses by ... , This is the first year that Concept Plus, LLC., ... with a 95.92% compound annual growth rate. “For Concept Plus ...
(Date:12/20/2014)... MissyDress, a distinguished special dress supplier, has just done ... drastically cut prices to all its prom dresses already, ... 2015. Many of the hottest styles are sold here ... and more. , A spokesman for MissyDress says, “The ... princess prom dresses or sweetheart chiffon prom dresses, you ...
(Date:12/20/2014)... company LunaDress has recently announced its 2015 collection ... discounts on all of its special occasion dresses & wedding ... perfect wedding gown. If you have no idea of what ... Many different wedding dress styles and our dress experts are ... the current special offer, up to 80% off," the CEO ...
(Date:12/20/2014)... 2014 (HealthDay News) -- The holidays can be anything ... with fresh trees, scented candles and other allergy triggers. ... decorations that have been packed away in dank basements ... and asthma patients," Dr. Rachna Shah, an affiliate faculty ... said in Loyola news release. Shah, who is ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:Holiday Trimmings Can Trigger Allergies 2
... ... allergy elimination as opposed to allergy prevention. Absolute Health is a unique healthcare facility ... symptoms caused by allergies that actually quell allergies as opposed to simply preventing them. ... Scottsdale, AZ ...
... incisions and often fewer complications, robotic surgery becomes a popular ... surgery often imagine themselves under the care of a trained ... cool disposition. , But that picture is changing. , The ... very well not be human. , Robotic surgery is becoming ...
... study by Danish researchers discovered patients with alcoholic cirrhosis ... of the disease diagnosis. Researchers noted that complications, ... predictors of mortality, but did not develop in a ... appear in the May issue of Hepatology , ...
... Elsevier, the world-leading publisher of scientific, technical and medical ... to the Clinics of North America series ... guidance of Consulting Editors Dr. Ranjan Thakur and Dr. ... topic that covers the most significant concerns in this ...
... the European College of Neuropsychopharmacology (ECNP) will be held ... the Netherlands. With more than 150 speakers from 20 ... world, the ECNP Congress is the largest annual scientific ... In more than 35 sessions experts will give insights ...
... ... ... April 27, 2010 -- Aerohive Networks , creators of the award-winning cooperative control ... Services NHS Trust, will significantly extend its existing Aerohive Networks’ WLAN infrastructure by adding ...
Cached Medicine News:Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 2Health News:Allergy Treatment from Absolute Health Provides Allergy Elimination as Opposed to Allergy Prevention 3Health News:Scalpels in Hand, Robots Take to the ER 2Health News:Scalpels in Hand, Robots Take to the ER 3Health News:Alcoholic cirrhosis patients had high prevalence of complications at diagnosis 2Health News:Elsevier introduces Cardiac Electrophysiology Clinics 2Health News:NHS Mid Essex Prescribes Wireless Network For New Hospital Wing 2
... allows for the restoration of shoulder ... replacement surgery. Backed by the clinical ... experience, the Bigliani/Flatow Shoulder System is ... mobility, balance, and stability with a ...
... system designed to provide easy ... combinations for optimal patient sizing. ... titanium stems. Non-porous cobalt chrome ... diameters and neck lengths. Standard ...
...
...
Medicine Products: